Antimicrobial Resistance Of Staphylococcus Aureus And Oral Streptococci Strains From High-risk Endocarditis Patients.

dc.creatorGroppo, Francisco Carlos
dc.creatorCastro, Flavia Meira
dc.creatorPacheco, Aline Barros
dc.creatorMotta, Rogerio Heladio
dc.creatorFilho, Thales Rocha de Mattos
dc.creatorRamacciato, Juliana Cama
dc.creatorFlorio, Flavia Martao
dc.creatorMeechan, John Gerard
dc.date
dc.date2015-11-27T13:02:40Z
dc.date2015-11-27T13:02:40Z
dc.date.accessioned2018-03-29T01:01:53Z
dc.date.available2018-03-29T01:01:53Z
dc.identifierGeneral Dentistry. v. 53, n. 6, p. 410-3
dc.identifier0363-6771
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/16366048
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/196527
dc.identifier16366048
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1296760
dc.descriptionThis study sought to determine the antimicrobial susceptibility of Staphylcoccus aureus and viridans group streptococci strains collected from the forearm skin and saliva of 30 patients at high risk of endocarditis. Agar susceptibility tests of antibiotics routinely utilized in dentistry were used to verify antimicrobial resistance of bacterial strains. Of the Staphylcoccus aureus strains, 50% were resistant to ampicillin, 53.3% to amoxicillin, 60.0% to penicillin G, 13.3% to amoxicillin/clavulanate, 20.0% to azithromycin, 27.6% to clarithromycin, 23.3% to erythromycin, 3.3% to cefazolin, and 6.7% to clindamycin. Regarding streptococci, 16.7% of the strains were resistant to ampicillin, 16.7% to amoxicillin, 23.3% to azithromycin, 23.3% to clarithromycin, 30.0% to erythromycin, 13.3% to cefazolin, 26.7% to clindamycin, 16.7% to penicillin G, and 3.3% to amoxicillin/clavulanate. Pathogens associated with bacterial endocarditis exhibited elevated resistance rates against the antibiotics used for prophylaxis in dentistry.
dc.description53
dc.description410-3
dc.languageeng
dc.relationGeneral Dentistry
dc.relationGen Dent
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAged
dc.subjectAmoxicillin
dc.subjectAmoxicillin-potassium Clavulanate Combination
dc.subjectAmpicillin
dc.subjectAnti-bacterial Agents
dc.subjectAzithromycin
dc.subjectCefazolin
dc.subjectClarithromycin
dc.subjectClindamycin
dc.subjectDisease Susceptibility
dc.subjectDrug Resistance, Bacterial
dc.subjectEndocarditis, Bacterial
dc.subjectErythromycin
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMicrobial Sensitivity Tests
dc.subjectMiddle Aged
dc.subjectPenicillin G
dc.subjectRisk Factors
dc.subjectSaliva
dc.subjectSkin
dc.subjectStaphylococcus Aureus
dc.subjectViridans Streptococci
dc.titleAntimicrobial Resistance Of Staphylococcus Aureus And Oral Streptococci Strains From High-risk Endocarditis Patients.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución